Sanofi Belgium

Sanofi is exploring new approaches to better understand the immune mechanisms common to many diseases. Through a unique combination of scientific innovation and artificial intelligence, we are pushing the boundaries of research to develop solutions that will transform patients' lives. The future of medicine is taking shape today, and we are proud to be part of it. #PursueProgress #DiscoverExtraordinary

Our 2nd episode of the Podcast Series: A Heart for Fabry is available now 🎙️   In this second episode, Prof. Tomas Robyns will discuss the cardiological impact of Fabry disease, focusing specifically on unexplained left ventricular hypertrophy, the techniques used to identify it and determine if a patient may have Fabry disease. What is the role of the cardiologist? Why is left ventricular hypertrophy a key symptom? And many more questions answered around Fabry. 🔊 Listen now to the cardiogenetics in Fabry disease episode: Unexplained left ventricular hypertrophy in Fabry with Prof. Tomas Robyns. https://lnkd.in/eQ64wvxq #Sanofi #FabryDisease #Cardiology #HealthcareProfessionals #Podcast 

A simple illness on holiday... and her life turns upside down. 🌍 Today, Kim's life is different, but more intense than ever! Discover her story of survival in the face of sepsis and how she turned this ordeal into strength. 💪✨ #PatientStory

When it comes to healthcare, we should all have the same rights: everyone should be able to access the same care, without exception. 🌍💙 That's why we launched the Global Health Unit to improve healthcare pathways in countries where access is still limited. In a few figures, find out where we are today 👇

🎙️ Our 1st episode of the Podcast Series: A Heart for Fabry is now available 🎙️ In this first episode Prof. Antoine Bondue will discuss the cardiological impact in Fabry disease patients and the key role of cardiologists in the diagnosis and monitoring of these patients.  ❔ What is the role of cardiologist? Why it is important to consider a multidisciplinary approach for Fabry diagnose? And many more questions answered around Fabry. 🔊 Listen now to the first episode Cardio Genetics in Fabry with Prof. Antoine Bondue : https://lnkd.in/dVcPdWu5 #Sanofi #FabryDisease #Cardiology #HealthcareProfessionals #Podcast 

Asking the right questions and engaging in dialogue with MS patients is essential for detecting - more quickly - the impact of the disease, which is often difficult to perceive. These discussions can also help to identify less visible processes of the disease, such as smoldering neuroinflammation. This chronic and progressive ‘smoldering neuroinflammation’ of the central nervous system plays a key role in the progression of disability, beyond the visible attacks, and often remains under-detected without in-depth understanding and appropriate tools. At Sanofi, with decades of expertise in neurology, we are conducting research to better understand these processes and improve the care of people with MS. Together, let's continue to learn and move forward for a better future. #PursueProgress #DiscoverExtraordinary

🎙️ Introducing Our New Podcast Series: A Heart for Fabry 🎙️ We are proud to present a three-part podcast series designed for cardiologists and healthcare professionals, focusing on the critical role of cardiologists in diagnosing and managing Fabry disease, a rare inherited disorder with significant cardiological implications. In "A Heart for Fabry," three esteemed cardiologists delve into specific aspects of Fabry disease: EPISODE 1: Cardio Genetics in Fabry Disease. Featuring Prof. Antoine Bondue, Cardiologist at Hôpital Erasme and President of the Scientific Committee of the Belgian Heart League. EPISODE 2: Unexplained Left Ventricular Hypertrophy in Fabry Disease. Featuring Prof. Tomas Robyns, Cardiologist at UZ Leuven. EPISODE 3: Unexplained Arrhythmias in Fabry Disease. Featuring Prof. Johan Saenen, Cardiologist at UZ Antwerpen. 🔊 Listen now below 👇 #Sanofi #FabryDisease #Cardiology #HealthcareProfessionals #Podcast  

“For me, the best way to end disability inequality is to get businesses involved.” Caroline Casey, member of the Board of Directors. This is the role she has decided to take on at Sanofi. Every day, she highlights the problem and proposes solutions to remedy it. For her, it is by respecting everyone's differences and adapting to everyone's needs that companies will inspire positive change. If companies lead the way, society will naturally follow. That's why we were mobilising at Sanofi to set an example: https://lnkd.in/eXx8mYTn

Making the difference between HIV and AIDS is more than just a distinction: it's a step towards better understanding and prevention. 🌍 1️⃣Knowing that HIV does not necessarily lead to AIDS helps us to understand how the disease develops. 2️⃣Early detection is becoming a priority in order to manage the infection before it progresses. 3️⃣By explaining this difference, we are reducing stigma and changing perceptions. 4️⃣Finally, we are reminding people of the importance of antiretroviral treatment, which enables HIV-positive people to live full lives. Together, let's work towards better information and greater inclusion! #WorldAidsDay

“Living with a chronic illness means becoming its ally”. So says Miléna, who suffers from atopic dermatitis. Don't miss her touching story ❤️ #PatientStory #AtopicDermatitis